Results for tag: "Specialty Injectable Generics"

Specialty Injectable Generics are a subset of generic drugs that are administered via injection. These drugs are typically used to treat serious medical conditions, such as cancer, rheumatoid arthritis, and multiple sclerosis. Specialty Injectable Generics are typically more expensive than other generic drugs, due to the complexity of their production and the specialized equipment required for their administration. The Specialty Injectable Generics market is highly competitive, with many companies vying for market share. Companies in this market include Mylan, Teva Pharmaceuticals, Sandoz, Fresenius Kabi, Hospira, and Baxter International. Show Less Read more